Open letter from ELSC calling on EU leaders to make life sciences a strategic priority
The newly formed European Life Sciences Coalition (ELSC) has sent an open letter to leading decision-makers and politicians in the EU and Sweden, urging them to take action.
June 29, 2026
The ELSC in association with Invest Europe and supported by more than 170 investors, companies and research organisations, has published an open letter calling on EU leaders to make life sciences a strategic priority for Europe’s competitiveness, resilience and health.
In focus: Europe at a crossroads
Scientific excellence in a fragmented market means Europe will either lead or fall behind in global biotech.
The message in the open letter, titled “Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry, is clear: mobilize more long-term capital, deepen European capital markets, simplify regulation and create the conditions for innovation to thrive.
New coalition aims to strengthen Europe’s life science investment ecosystem
The European Life Sciences Coalition (ELSC) aims to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector.
“The exceptionally strong response we have received – nearly twice as many signatories as our original target – underscores the growing momentum in our work to strengthen Europe’s life sciences ecosystem and its competitiveness,” HealthCap, one of the ELSC members, wrote in a comment.
Published: June 29, 2026
